Wednesday, October 9, 2019

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug The tentative nod granted by US Food Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for multiple strengths of dimethyl fumarate delayed-release capsules of 120 mg and 240 mg.

from Moneycontrol Business News https://ift.tt/2LWLFDH
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...